In vivo inhibition of nitric oxide synthesis does not depend on renin-angiotensin system activation

European Journal of Pharmacology
A ZappelliniG de Nucci

Abstract

The role of the renin-angiotensin system in the haemodynamic changes induced by acute administration of N omega-nitro-L-arginine methyl ester in anaesthetised dogs was investigated. The left femoral artery and vein were cannulated for blood pressure measurement and drug administration, respectively. A Swan-Ganz catheter was introduced through the right femoral vein and advanced to the pulmonary artery. Pulmonary arterial pressure, right atrial pressure and cardiac output were also determined. N omega-Nitro-L-arginine methyl ester (0.01-10.0 mg/kg) was administered alone (control animals, n = 18) or in the presence of the angiotensin-converting enzyme inhibitors, captopril (2 mg/kg, n = 9) or enalapril (2 mg/kg, n = 7) or of the bradykinin B2 receptor antagonist D-[Arg-Hyp3, Thi5, D-Tic7, Oic8]bradykinin (Hoe 140, 0.1 mg/kg, n = 6). Cerebellum nitric oxide synthase and serum angiotensin-converting enzyme activities were also measured. N omega-Nitro-L-arginine methyl ester induced dose-dependent increases in blood pressure and systemic vascular resistance and decreases in heart rate and cardiac output. Nitric oxide synthase activity was inhibited 58% by N omega-nitro-L-arginine methyl ester (from 3.37 +/- 0.30 to 1.40 +/- 0.24 pm...Continue Reading

References

Mar 1, 1991·British Journal of Pharmacology·K WirthJ Knolle
Apr 30, 1990·Biochemical and Biophysical Research Communications·U FörstermannF Murad
Aug 1, 1991·The American Journal of Physiology·R Zatz, G de Nucci
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D D ReesS Moncada
Jan 1, 1987·The Journal of Clinical Investigation·D J Campbell
Jul 1, 1971·Biochemical Pharmacology·D W Cushman, H S Cheung
Apr 1, 1971·The American Journal of Cardiology·W GanzH J Swan
Dec 30, 1993·The New England Journal of Medicine·S Moncada, A Higgs
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·K SchrickerA Kurtz
Jan 1, 1994·Journal of Cardiovascular Pharmacology·M FalkenhahnT Unger
Dec 1, 1993·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension· NafrialdiA Mimran
Oct 1, 1993·Naunyn-Schmiedeberg's Archives of Pharmacology·E M van GelderenP R Saxena
Aug 1, 1993·Hypertension·D H Sigmon, W H Beierwaltes
Jun 1, 1993·Acta Physiologica Scandinavica·P A NaessF Kiil
Mar 1, 1993·Hypertension·J DananbergR J Grekin
May 1, 1996·Basic Research in Cardiology·H MorenoG de Nucci
Jan 1, 1954·Quarterly Journal of Experimental Physiology and Cognate Medical Sciences·G FEGLER

❮ Previous
Next ❯

Citations

Feb 28, 2007·Clinical and Experimental Pharmacology & Physiology·Cristina E OkuyamaGilberto De Nucci
May 23, 2001·Experimental Biology and Medicine·B Martínez-Nieves, J C Dunbar
Dec 9, 1998·The American Journal of Physiology·A Kurtz, C Wagner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.